Dow Up 1.63% Nasdaq Up 0.97%

Lpath Inc. (LPTN)

-NasdaqCM
3.07 Oct 17, 4:00PM EDT
Prev Close:3.07
Open:N/A
Bid:2.86 x 500
Ask:3.35 x 100
1y Target Est:14.00
Beta:0.05
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:2.75 - 5.36
Volume:0
Avg Vol (3m):39,312
Market Cap:47.95M
P/E (ttm):N/A
EPS (ttm):-0.77
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for LPTN

Key Statistics

Forward P/E (1 yr):76.75
P/S (ttm):6.06
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.13
Quarterly EPS Est (Sep-14) :-0.33
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Lpath, Inc., a biotechnology company, focuses on the discovery and development of lipidomic-based therapeutic antibodies for treating a range of human diseases primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback